Hosted on MSN1mon
Who do Americans trust for health information? Poll finds gap between FDA and RFK Jr.Similarly, 62% and 60%, respectively, said they trust health information provided by the National Institute of Health (NIH) and the Food and Drug Administration (FDA). Forty-five percent said they ...
In addition, in June 2024, IBI343 was granted Fast Track Designation by the US Food and Drug Administration (FDA) for the treatment of advanced ... including gastric cancer.” NMPA Breakthrough Therapy ...
and Breakthrough Therapy Designations by both the US FDA and China’s NMPA for the treatment of patients with locally advanced or metastatic ROS1-positive NSCLC. Based on pooled results of the TRUST-I ...
Zhaoke Ophthalmology Limited is responsible for developing and obtaining regulatory approval for NVK-002 in Greater China, ...
Innovent & ASK Pharm Announce NMPA Approval Of Limertinib,3rd-Gen EGFR TKI For Lung Cancer Treatment
(RTTNews) - Innovent Biologics Inc. (IVBXF.OB) and Jiangsu Aosaikang Pharmaceutical Co. Ltd. or ASK Pharm announced that China's National Medical Products Administration (NMPA) has approved the ...
IceCure Medical has submitted a regulatory filing to China's National Medical Products Administration (NMPA) seeking the approval of its ProSense cryoablation system, which is designed for ...
Bio-Thera has filed for regulatory approval of BAT2206 with the China National Medical Products Administration (NMPA), the European ... and Drug Administration (FDA). Also on December 24, 2024 ...
A separate NDA for the first-line treatment in adult patients with locally advanced or metastatic NSCLC carrying EGFR exon 19 deletions or exon 21 L858R mutations is currently under NMPA review.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback